Gilead to buy cancer drugmaker Immunomedics for $21 billion By John Benoit - September 14, 2020 0 53 Facebook Twitter Google+ Pinterest WhatsApp (Reuters) – Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by gaining acce… Read More